RMD (ResMed Inc.) Stock Financials & Earnings | Market Cap Arena

RMD (ResMed Inc.) Stock Financials & Earnings | Market Cap Arena

RMDResMed Inc.

Mkt Cap$36B

Healthcare·Medical - Instruments & Supplies·🇺🇸 United States·NYSE

Revenue (TTM)$5.4B

Net Income (TTM)$1.5B

EPS (TTM)$10.11

Free Cash Flow (TTM)$1.8B

Gross Margin61.0%

Op. Margin33.8%

Net Margin27.5%

FCF Margin33.1%

P/S Ratio (TTM)6.7x

P/E Ratio (TTM)24.4x

YoY Rev Growth+9.6%

Employees—

Earnings Reports

Revenue & Profitability

Quarter	Revenue	Gross Profit	Op. Income
Q3 23	$1.1B	$618M	$301M
Q4 23	$1.1B	$617M	$275M
Q1 24	$1.1B	$600M	$289M
Q2 24	$1.2B	$669M	$275M
Q3 24	$1.2B	$682M	$375M
Q4 24	$1.2B	$704M	$381M
Q1 25	$1.2B	$717M	$387M
Q2 25	$1.3B	$751M	$417M
Q3 25	$1.3B	$766M	$426M
Q4 25	$1.3B	$820M	$455M
Q1 26	$1.3B	$821M	$447M
Q2 26	$1.4B	$885M	$498M

Revenue Breakdown

Valuation

Quarter	P/S	P/E
Q3 23	9.0x	42.0x
Q4 23	8.6x	40.3x
Q1 24	8.3x	39.9x
Q2 24	8.0x	40.7x
Q3 24	7.9x	37.8x
Q4 24	7.7x	35.5x
Q1 25	7.5x	32.5x
Q2 25	7.3x	29.0x
Q3 25	7.2x	27.6x
Q4 25	7.0x	25.8x
Q1 26	6.9x	25.2x
Q2 26	6.7x	24.4x

Operating Cash Flow

Quarter	Operating CF	Free CF
Q3 23	$283M	$251M
Q4 23	$237M	$199M
Q1 24	$286M	$245M
Q2 24	$273M	$249M
Q3 24	$402M	$379M
Q4 24	$440M	$414M
Q1 25	$326M	$306M
Q2 25	$309M	$290M
Q3 25	$579M	$555M
Q4 25	$539M	$508M
Q1 26	$457M	$414M
Q2 26	$340M	$311M

Capital Expenditures

CapEx

Quarter	CapEx
Q3 23	$31M
Q4 23	$39M
Q1 24	$41M
Q2 24	$23M
Q3 24	$23M
Q4 24	$26M
Q1 25	$20M
Q2 25	$19M
Q3 25	$24M
Q4 25	$31M
Q1 26	$43M
Q2 26	$29M

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q3 23	+29.2%	+29.5%
Q4 23	+22.7%	+28.4%
Q1 24	+16.0%	+20.6%
Q2 24	+12.5%	+17.8%
Q3 24	+7.2%	+0.8%
Q4 24	+9.0%	-0.6%
Q1 25	+11.1%	+2.9%
Q2 25	+10.3%	-2.6%
Q3 25	+7.9%	+5.2%
Q4 25	+10.2%	+6.1%
Q1 26	+9.1%	+6.2%
Q2 26	+11.0%	+7.0%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q3 23	$18M	1.6%
Q4 23	$20M	1.8%
Q1 24	$19M	1.7%
Q2 24	$20M	1.7%
Q3 24	$20M	1.7%
Q4 24	$21M	1.7%
Q1 25	$20M	1.6%
Q2 25	$23M	1.8%
Q3 25	$24M	1.9%
Q4 25	$25M	1.8%
Q1 26	$21M	1.6%
Q2 26	$29M	2.0%

OpEx Breakdown

Quarter	R&D	SG&A
Q3 23	$76M	$228M
Q4 23	$78M	$241M
Q1 24	$76M	$223M
Q2 24	$74M	$222M
Q3 24	$77M	$230M
Q4 24	$81M	$242M
Q1 25	$80M	$239M
Q2 25	$81M	$242M
Q3 25	$84M	$245M
Q4 25	$86M	$265M
Q1 26	$87M	$259M
Q2 26	$91M	$278M

Revenue Segments

Quarter	Sleep And Respiratory	Software As Service	Residential Care Software
Q3 23	$980M	$137M	—
Q4 23	$983M	$139M	—
Q1 24	$963M	$139M	—
Q2 24	$1.0B	$145M	—
Q3 24	$1.0B	$148M	—
Q4 24	$1.1B	$152M	—
Q1 25	$1.1B	—	$157M
Q2 25	$1.1B	—	$156M
Q1 26	$1.2B	—	$166M
Q2 26	$1.3B	—	$167M

Revenue by Geography

Quarter	Combined Europe Asia And Other Markets	Software As Service	Us Canada And Latin America	Global	Sleep And Respiratory
Q3 23	$351M	$137M	$629M	—	—
Q4 23	—	—	—	$1.1B	—
Q2 24	$349M	—	$669M	—	$145M
Q3 24	$362M	—	$687M	—	$148M
Q1 25	$360M	—	$707M	$157M	—
Q2 25	$377M	—	$749M	$156M	—
Q1 26	$395M	—	$775M	$166M	—
Q2 26	$421M	—	$835M	$167M	—

War Chest

Quarter	Cash	Short-term Investments	Total
Q3 23	$228M	$0	$228M
Q4 23	$228M	$0	$228M
Q1 24	$209M	$0	$209M
Q2 24	$210M	$0	$210M
Q3 24	$238M	$0	$238M
Q4 24	$238M	$0	$238M
Q1 25	$426M	$0	$426M
Q2 25	$522M	$0	$522M
Q3 25	$933M	$12M	$945M
Q4 25	$1.2B	$0	$1.2B
Q1 26	$1.4B	$0	$1.4B
Q2 26	$1.4B	$9M	$1.4B

Shares Outstanding

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change
Q3 23	147M	-0.0%
Q4 23	148M	+0.1%
Q1 24	147M	-0.0%
Q2 24	148M	+0.0%
Q3 24	147M	-0.1%
Q4 24	148M	+0.1%
Q1 25	148M	+0.0%
Q2 25	148M	+0.0%
Q3 25	147M	-0.3%
Q4 25	147M	-0.1%
Q1 26	147M	+0.0%
Q2 26	147M	+0.0%

Revenue Per Employee

Revenue / Employee

Year	Revenue/Employee	Employees
FY 14	$379K	4K
FY 15	$387K	4K
FY 16	$350K	5K
FY 17	$340K	6K
FY 18	$394K	6K
FY 19	$360K	7K
FY 20	$381K	8K
FY 21	$401K	8K
FY 22	$438K	8K
FY 23	$416K	10K
FY 24	$469K	10K
FY 25	$486K	11K